Royce & Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-294,800
| Closed | -$1.27M | – | 1191 |
|
|
2019
Q3 | $1.27M | Buy |
294,800
+57,100
| +24% | +$247K | 0.01% | 773 |
|
|
2019
Q2 | $948K | Sell |
237,700
-80,000
| -25% | -$319K | 0.01% | 842 |
|
|
2019
Q1 | $1.7M | Hold |
317,700
| – | – | 0.01% | 780 |
|
|
2018
Q4 | $1.63M | Sell |
317,700
-76,669
| -19% | -$393K | 0.01% | 784 |
|
|
2018
Q3 | $3.83M | Sell |
394,369
-18,500
| -4% | -$179K | 0.03% | 663 |
|
|
2018
Q2 | $4.21M | Buy |
412,869
+23,200
| +6% | +$237K | 0.03% | 638 |
|
|
2018
Q1 | $5.07M | Buy |
389,669
+29,400
| +8% | +$382K | 0.04% | 564 |
|
|
2017
Q4 | $6.45M | Buy |
360,269
+67,069
| +23% | +$1.2M | 0.04% | 514 |
|
|
2017
Q3 | $7.36M | Buy |
293,200
+10,300
| +4% | +$259K | 0.05% | 464 |
|
|
2017
Q2 | $6.82M | Buy |
282,900
+150,300
| +113% | +$3.62M | 0.05% | 497 |
|
|
2017
Q1 | $2.55M | Buy |
+132,600
| New | +$2.55M | 0.02% | 787 |
|